AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · IEX Real-Time Price · USD
7.18
+0.23 (3.31%)
At close: Jul 19, 2024, 4:00 PM
7.00
-0.18 (-2.51%)
Pre-market: Jul 22, 2024, 8:56 AM EDT
AngioDynamics Employees
AngioDynamics had 815 employees as of May 31, 2023. The number of employees increased by 55 or 7.24% compared to the previous year.
Employees
815
Change (1Y)
55
Growth (1Y)
7.24%
Revenue / Employee
$397,556
Profits / Employee
-$236,033
Market Cap
287.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MeiraGTx Holdings | 425 |
Poseida Therapeutics | 330 |
Omeros | 198 |
Akebia Therapeutics | 167 |
Alimera Sciences | 159 |
Prelude Therapeutics | 128 |
Orchestra BioMed Holdings | 56 |
ANGO News
- 5 days ago - Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance - Benzinga
- 6 days ago - AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results - Business Wire
- 13 days ago - AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024 - Business Wire
- 2 months ago - AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System - Business Wire
- 2 months ago - AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions - Business Wire
- 3 months ago - AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture - Business Wire
- 3 months ago - AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE - Business Wire
- 3 months ago - AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. - Business Wire